Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma
Clinical trial NCT06846489 · RECRUITING
Trial details
- NCT number
- NCT06846489
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-14
- Primary completion
- 2033-02-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.